Insider · CIK 0001858748
Roger Sawhney
director
Files at ABUS (Arbutus Biopharma Corp), ACTU (ACTUATE THERAPEUTICS, INC.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | ABUS Arbutus Biopharma Corp | DDisposition to issuer Common Shares | -17,142 | $5.00 | $86k | 13,683 | 5 d ago |
| Sep 18, 2026 | ABUS Arbutus Biopharma Corp | MOption exercise Common Shares | +52,533 | $3.34 | $175k | 52,533 | 19 d ago |
| Sep 18, 2026 | ABUS Arbutus Biopharma Corp | MOption exercise Common Shares | +78,800 | $4.24 | $334k | 131,333 | 19 d ago |
| Sep 18, 2026 | ABUS Arbutus Biopharma Corp | FTax withholding Common Shares | -100,508 | $5.07 | $510k | 30,825 | 19 d ago |
| Sep 18, 2026 | ABUS Arbutus Biopharma Corp | MOption exercise Stock Option (Right to Buy)derivative | -52,533 | $0.00 | $0 | 105,067 | 19 d ago |
| Sep 18, 2026 | ABUS Arbutus Biopharma Corp | MOption exercise Stock Option (Right to Buy)derivative | -78,800 | $0.00 | $0 | 0 | 19 d ago |
| Aug 4, 2025 | ABUS Arbutus Biopharma Corp | AGrant or award Stock Option (Right to Buy)derivative | +157,600 | $0.00 | $0 | 157,600 | Aug 6, 2025 |
| May 22, 2025 | ACTU ACTUATE THERAPEUTICS, INC. | AGrant or award Stock Optionsderivative | +15,000 | $0.00 | $0 | 15,000 | May 23, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.